Biotechnology
The biotech sector has been buzzing hot amid the COVID-19 vaccine rollout and mega-merger activity. British pharmaceutical company AstraZeneca plc AZN has agreed to buy rare-disease specialist Alexion Pharmaceuticals ALXN for $39 billion. The deal ... [Read]